Non-Alcoholic Fatty Liver Disease (NAFLD) Management in the Community

Area of Science:

• Hepatology
• Metabolic Diseases
• Public Health

Background:

• Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent globally and in Korea, posing a significant health burden.
• NAFLD is strongly associated with metabolic conditions such as obesity, type 2 diabetes (T2D), and dyslipidemia, all linked to insulin resistance.
• The disease spectrum ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), with advanced fibrosis being a critical predictor of liver-related outcomes.

Purpose of the Study:

• To review the current understanding of NAFLD in the Korean context.
• To highlight the prognostic significance of metabolic syndrome components and advanced liver fibrosis.
• To discuss therapeutic strategies, including combination treatments and lifestyle modifications.

Main Methods:

• Literature review and synthesis of existing research on NAFLD.
• Analysis of the association between NAFLD, metabolic syndrome, and T2D.
• Evaluation of current and potential therapeutic interventions for NAFLD.

Main Results:

• NAFLD is a leading cause of liver disease in Korea and is projected to become a major cause of cirrhosis and hepatocellular carcinoma.
• Advanced liver fibrosis, assessed non-invasively, and metabolic syndrome components are crucial prognostic indicators.
• Current therapies for NAFLD have modest effects, necessitating combination treatments and lifestyle interventions.

Conclusions:

• NAFLD represents a significant and growing public health challenge, particularly in Korea.
• Effective management requires a comprehensive approach, integrating lifestyle changes, weight reduction, and potentially combination therapies.
• Further research into novel therapeutic strategies is warranted given the disease's complexity and heterogeneity.